Phase II trial of adjuvant chemotherapy with carboplatin plus TS1 followed by maintenance TS1 in patients with completely resected stage II/IIIA non-small cell lung cancer. (JNETS1302) - Adjuvant trial of CBDCA+TS1 followed by TS1 in completely resected stage II/IIA lung cancer. (JNETS1302)

Japanese Northern East Area Thoracic Surgery Study Group (JNETS)0 个研究点目标入组 40 人开始时间: 2013年7月29日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray 2. With history of radiotherapy and/or chemotherapy for other disease including other cancer 3. With synchronous or metachronous (within 5 year before entry) multiple lung cancer 4. With synchronous or metachronous (within 5 year before entry) double cancer, except for curable cancer by local therapy such as in situ carcinoma 5. Severe surgical complication 6. Severe drug allergy 7. Severe complication; such as uncontrollable diabetes mellitus or hypertension 8. Positive for HBs antigen, HBs antibody, HBC antibody, HCV antibody or HIV antibody 9.Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 10. Men who have willing to become partner's pregnant 11.Physician concludes that the patient's participation in this trial is inappropriate

发起方

Japanese Northern East Area Thoracic Surgery Study Group (JNETS)